Viewing Study NCT04354402


Ignite Creation Date: 2025-12-25 @ 4:04 AM
Ignite Modification Date: 2025-12-26 @ 2:59 AM
Study NCT ID: NCT04354402
Status: COMPLETED
Last Update Posted: 2023-04-18
First Post: 2020-04-16
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Follow-up Study of SyB L-0501 in Combination With Rituximab to Treat DLBCL
Sponsor: SymBio Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module